Literature DB >> 5041520

Antiandrogen (cyproterone acetate) therapy in deviant hypersexuality.

A J Cooper, A A Ismail, A L Phanjoo, D L Love.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5041520     DOI: 10.1192/bjp.120.554.59

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  8 in total

1.  Orgasmic frequency and plasma testosterone levels in normal human males.

Authors:  H C Kraemer; H B Becker; H K Brodie; C H Doering; R H Moos; D A Hamburg
Journal:  Arch Sex Behav       Date:  1976-03

2.  The control of deviant sexual behavior by drugs: a double-blind controlled study of benperidol, chlorpromazine, and placebo.

Authors:  G Tennent; J Bancroft; J Cass
Journal:  Arch Sex Behav       Date:  1974-05

3.  Effects of cyproterone acetate on sexual arousal patterns of pedophiles.

Authors:  J M Bradford; A Pawlak
Journal:  Arch Sex Behav       Date:  1993-12

4.  Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration.

Authors:  L Rousseau; A Dupont; F Labrie; M Couture
Journal:  Arch Sex Behav       Date:  1988-02

5.  Plasma testosterone levels of sexually functional and dysfunctional men.

Authors:  M F Schwartz; R C Kolodny; W H Masters
Journal:  Arch Sex Behav       Date:  1980-10

6.  Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias.

Authors:  J M Bradford; A Pawlak
Journal:  Arch Sex Behav       Date:  1993-10

7.  Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders.

Authors:  J P Wincze; S Bansal; M Malamud
Journal:  Arch Sex Behav       Date:  1986-08

8.  Predictors of Compulsive Sexual Behavior Among Treatment-Seeking Women.

Authors:  Ewelina Kowalewska; Mateusz Gola; Michał Lew-Starowicz; Shane W Kraus
Journal:  Sex Med       Date:  2022-05-30       Impact factor: 2.523

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.